PMRT for T1-2, N1-3 positive BC patients has to be reconsidered according to the prognostic factors and the decision has to be made individually with the consideration of long-term morbidity and with the patient approval.
Authors: Ruşen Coşar, Cem Uzal, Füsun Tokatlı, Bengü Denizli, Mert Saynak, Nesrin Turan, Sernaz Uzunoğlu, Alaattin Özen, Ahmet Sezer, Kamuran İbiş, Burcu Üregen, Vuslat Yurut‐Caloglu, Zafer Koçak
DOI: https://doi.org/10.1186/1748-717x-6-28
Publish Year: 2011
